Skip to main content
. 2018 Oct 19;9(6):2347–2356. doi: 10.1007/s13300-018-0522-1

Table 2.

The glucose profiles in the different injection periods

Parameters Patient injection period Nurse injection period P value
MG (mmol/L) 9.5 ± 2.2 8.3 ± 1.9 0.00
SD (mmol/L) 2.2 ± 1.0 2.0 ± 0.9 0.03
MAGE (mmol/L) 5.4 (3.7, 7.9) 3.8 (2.8, 5.4) 0.00
AUC > 10 mmol/L (mmol/L/day)a 0.7 (0.1, 1.7) 0.1 (0.0, 1.0) 0.00
AUC < 3.9 mmol/L (mmol/L/day)b 0.0 (0.0, 0.0) 0.0 (0.0, 0.0) 0.13
Percentage of time in hyperglycemia (%)c 30.7 (9.8, 53.8) 13.7 (2.3, 37.1) 0.00
Percentage of time in normoglycemia (%)d 69.3 (46.2, 88.2) 86.1 (61.5, 95.1) 0.00
Percentage of time in hypoglycemia (%)e 0.0 (0.0, 0.0) 0.0 (0.0, 0.0) 0.10

Data are presented as mean ± standard deviation (SD) or as the median with the interquartile range (IQR; (25th, 75th percentile) in parenthesis

MG 24-h mean glucose concentration, SD standard deviation of MG, MAGE 24-h mean amplitude of glycemic excursion, AUC area under the curve

aAUC > 10 mmol/L is the incremental area under the curve of plasma glucose > 10.0 mmol/L

bAUC < 3.9 mmol/L is the incremental area under curve of plasma glucose < 3.9 mmol/L

cPercentage of time in hyperglycemia is the percentage of time the patient is is a hyperglycemic state (glucose level > 10 mmol/L)

dPercentage of time in normoglycemia is the percentage of time the patient is in a normoglycemic state (glucose level from 3.9 to 10 mmol/L)

ePercentage of time in hypoglycemia is the percentage of time the patient is in a hypoglycemic state (glucose level < 3.9 mmol/L)